Annual report pursuant to Section 13 and 15(d)

Restatement of Quarterly Financial Information (Unaudited) (Tables)

v3.22.2.2
Restatement of Quarterly Financial Information (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2021
Restatement of Quarterly Financial Information (Unaudited)  
Restatement of previously issued financial statements

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

As Previously

    

Network

    

Preferred Returns

    

Class A Units

    

Revenue

    

​

​

​

​

Reported

​

Adjustments

​

Adjustments

​

Adjustment

​

Adjustments

​

As Restated

Condensed Consolidated Balance Sheet as of September 30, 2021 (Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Class A Units Subject to Possible Redemption

​

$

—

​

$

—

​

$

—

​

$

43,656,270

​

$

—

​

$

43,656,270

Class D Units Subject to Possible Redemption

​

​

54,936,716

​

​

—

​

​

(7,895,162)

​

​

—

​

​

—

​

​

47,041,554

Contributed Capital

​

​

41,764,270

​

​

—

​

​

—

​

​

(41,764,270)

​

​

—

​

​

—

Class A Preferred Returns

​

​

6,594,660

​

​

—

​

​

(6,594,660)

​

​

—

​

​

—

​

​

—

Accumulated Equity-Based Compensation

​

​

2,747,960

​

​

—

​

​

—

​

​

(921,092)

​

​

—

​

​

1,826,868

Retained Loss from Non-Controlling Interests

​

 

(26,231,059)

​

 

26,231,059

​

​

—

​

​

—

​

​

—

​

 

—

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

​

​

(203,942,517)

​

​

(26,231,059)

​

​

14,489,765

​

​

(970,908)

​

​

—

​

​

(216,654,719)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Nine Months Ended September 30, 2021 (Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capitated Revenue

​

$

447,137,121

​

$

—

​

$

—

​

$

—

​

$

(3,539,071)

​

$

443,598,050

Other Patient Service Revenue

​

​

12,366,111

​

​

—

​

​

—

​

​

—

​

​

(3,893,823)

​

​

8,472,288

Total Operating Revenue

​

​

459,503,232

​

​

—

​

​

—

​

​

—

​

​

(7,432,894)

​

​

452,070,338

Medical Expenses

​

​

459,233,085

​

​

—

​

​

—

​

​

—

​

​

(899,940)

​

​

458,333,145

Total Operating Expenses

​

​

520,053,309

​

​

—

​

​

—

​

​

—

​

​

(899,940)

​

​

519,153,369

Operating Loss

​

​

(60,550,077)

​

​

—

​

​

—

​

​

—

​

​

(6,532,954)

​

​

(67,083,031)

Interest Expense, net

​

​

(13,130,628)

​

​

—

​

​

6,107,441

​

​

—

​

​

—

​

​

(7,023,187)

Total Other Expenses

​

​

(25,193,893)

​

​

—

​

​

6,107,441

​

​

—

​

​

—

​

​

(19,086,452)

Net Loss Attributable to Non-Controlling Interests

​

​

(8,043,678)

​

​

8,043,678

​

​

—

​

​

—

​

​

—

​

​

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

​

(77,700,292)

​

​

(8,043,678)

​

​

6,107,441

​

​

—

​

​

(6,532,954)

​

​

(86,169,483)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Three Months Ended September 30, 2021 (Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capitated Revenue

​

$

152,276,992

​

$

—

​

$

—

​

$

—

​

​

796,003

​

$

153,072,995

Other Patient Service Revenue

​

​

4,243,263

​

​

—

​

​

—

​

​

—

​

​

(1,130,303)

​

​

3,112,960

Total Operating Revenue

​

​

156,520,255

​

​

—

​

​

—

​

​

—

​

​

(334,300)

​

​

156,185,955

Medical Expenses

​

​

161,662,423

​

​

—

​

​

—

​

​

—

​

​

(334,300)

​

​

161,328,123

Total Operating Expenses

​

​

184,643,797

​

​

—

​

​

—

​

​

—

​

​

(334,300)

​

​

184,309,497

Interest Expense, net

​

​

(4,643,254)

​

​

—

​

​

2,114,063

​

​

—

​

​

—

​

​

(2,529,191)

Total Other Expenses

​

​

(6,044,940)

​

​

—

​

​

2,114,063

​

​

—

​

​

—

​

​

(3,930,877)

Net Loss Attributable to Non-Controlling Interests

​

​

(2,801,965)

​

​

2,801,965

​

​

—

​

​

—

​

​

—

​

​

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

​

(31,366,517)

​

​

(2,801,965)

​

​

2,114,063

​

​

—

​

​

—

​

​

(32,054,419)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Changes in Members' Deficit for the Nine Months Ended September 30, 2021

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Preferred Return at 8% for Class A Units

​

$

2,779,619

​

$

—

​

$

(2,779,619)

​

$

—

​

​

—

​

$

—

Net Loss

​

​

(85,743,970)

​

​

—

​

​

6,107,441

​

​

—

​

​

(6,532,954)

​

​

(86,169,483)

Balance as of September 30, 2021

​

​

(179,246,686)

​

​

—

​

​

7,895,167

​

​

(43,656,331)

​

​

—

​

​

(215,007,850)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Changes in Members' Deficit for the Three Months Ended September 30, 2021

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Preferred Return at 8% for Class A Units

​

$

962,163

​

$

—

​

$

(962,163)

​

$

—

​

​

—

​

$

—

Net Loss

​

​

(34,168,482)

​

​

—

​

​

2,114,063

​

​

—

​

​

—

​

​

(32,054,419)

Balance as of September 30, 2021

​

​

(179,246,686)

​

​

—

​

​

7,895,167

​

​

(43,656,331)

​

​

—

​

​

(215,007,850)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2021

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net Loss

​

$

(85,743,970)

​

$

—

​

$

6,107,441

​

$

—

​

​

(6,532,954)

​

$

(86,169,483)

Health Plan Settlements Receivable/Premiums Receivable

​

​

(7,417,477)

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

(884,523)

Class A and Class D Preferred Returns

​

​

6,107,441

​

​

—

​

​

(6,107,441)

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As Previously

    

Network

    

Preferred Returns

    

Class A Units

    

Revenue

​

    

​

​

    

Reported

    

Adjustments

    

Adjustments

    

Adjustments

    

Adjustment

    

As Restated

Condensed Consolidated Balance Sheet as of June 30, 2021 (Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Class A Units Subject to Possible Redemption

​

$

—

​

$

—

​

$

—

​

$

43,656,270

​

$

—

​

$

43,656,270

Class D Units Subject to Possible Redemption

​

​

53,784,760

​

​

—

​

​

(6,743,207)

​

​

—

​

​

—

​

​

47,041,553

Contributed Capital

​

​

41,764,270

​

​

—

​

​

—

​

​

(41,764,270)

​

​

—

​

​

—

Class A Preferred Returns

​

​

5,632,496

​

​

—

​

​

(5,632,496)

​

​

—

​

​

—

​

​

—

Accumulated Equity-Based Compensation

​

​

2,392,875

​

​

—

​

​

—

​

​

(921,092)

​

​

—

​

​

1,471,783

Retained Loss from Non-Controlling Interests

​

 

(23,429,094)

​

 

23,429,094

​

​

—

​

​

—

​

​

—

​

 

—

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

​

​

(172,576,003)

​

​

(23,429,094)

​

​

12,375,705

​

​

(970,908)

​

​

—

​

​

(184,600,300)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Six Months Ended June 30, 2021 (Unaudited)

​

 

​

​

 

​

​

​

​

​

​

​

​

​

​

​

 

​

Capitated Revenue

​

$

294,860,130

​

$

—

​

$

—

​

$

—

​

$

(4,335,073)

​

$

290,525,057

Other Patient Service Revenue

​

​

8,122,849

​

​

—

​

​

—

​

​

—

​

​

(2,763,520)

​

​

5,359,329

Total Operating Revenue

​

​

302,982,979

​

​

—

​

​

—

​

​

—

​

​

(7,098,593)

​

​

295,884,386

Medical Expenses

​

​

297,570,662

​

​

—

​

​

—

​

​

—

​

​

(565,640)

​

​

297,005,022

Total Operating Expenses

​

​

335,409,517

​

​

—

​

​

—

​

​

—

​

​

(565,640)

​

​

334,843,877

Operating Loss

​

​

(32,426,538)

​

​

—

​

​

—

​

​

—

​

​

(6,532,953)

​

​

(38,959,491)

Interest Expense, net

​

​

(8,487,374)

​

​

—

​

​

3,993,325

​

​

—

​

​

—

​

​

(4,494,049)

Total Other Expenses

​

​

(19,148,953)

​

​

—

​

​

3,993,325

​

​

—

​

​

—

​

​

(15,155,628)

Net Loss Attributable to Non-Controlling Interests

​

​

(5,241,713)

​

​

5,241,713

​

​

—

​

​

—

​

​

—

​

​

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(46,333,778)

​

 

(5,241,713)

​

​

3,993,325

​

​

—

​

​

(6,532,953)

​

 

(54,115,119)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Three Months Ended June 30, 2021 (Unaudited)

​

 

​

​

 

​

​

​

​

​

​

​

​

​

​

​

 

​

Capitated Revenue

​

$

147,159,665

​

$

—

​

$

—

​

$

—

​

$

(5,598,799)

​

$

141,560,866

Other Patient Service Revenue

​

​

4,258,933

​

​

—

​

​

—

​

​

—

​

​

(1,233,356)

​

​

3,025,577

Total Operating Revenue

​

​

151,418,598

​

​

—

​

​

—

​

​

—

​

​

(6,832,155)

​

​

144,586,443

Medical Expenses

​

​

150,679,717

​

​

—

​

​

—

​

​

—

​

​

(299,200)

​

​

150,380,517

Total Operating Expenses

​

​

170,856,707

​

​

—

​

​

—

​

​

—

​

​

(299,200)

​

​

170,557,507

Operating Loss

​

​

(19,438,108)

​

​

—

​

​

—

​

​

—

​

​

(6,532,955)

​

​

(25,971,063)

Interest Expense, net

​

​

(4,406,240)

​

​

—

​

​

2,036,476

​

​

—

​

​

—

​

​

(2,369,764)

Total Other Expenses

​

​

(5,529,823)

​

​

—

​

​

2,036,476

​

​

—

​

​

—

​

​

(3,493,347)

Net Loss Attributable to Non-Controlling Interests

​

​

(1,959,421)

​

​

1,959,421

​

​

—

​

​

—

​

​

—

​

​

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(23,008,510)

​

 

(1,959,421)

​

​

2,036,476

​

​

—

​

​

(6,532,955)

​

 

(29,464,410)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Changes in Members' Deficit for the Six Months Ended June 30, 2021

​

 

​

​

 

​

​

​

​

​

​

​

​

​

​

​

 

​

Preferred Return at 8% for Class A Units

​

$

1,817,564

​

$

—

​

$

(1,817,564)

​

$

—

​

​

—

​

$

—

Net Loss

​

 

(51,575,491)

​

 

—

​

​

3,993,325

​

​

—

​

​

(6,532,953)

​

 

(54,115,119)

Balance as of June 30,2021

​

​

(146,395,455)

​

​

—

​

​

6,743,106

​

​

(43,656,170)

​

​

—

​

​

(183,308,519)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Changes in Members' Deficit for the Three Months Ended June 30, 2021

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Preferred Return at 8% for Class A Units

​

$

926,852

​

$

—

​

$

(926,852)

​

$

—

​

​

—

​

$

—

Net Loss

​

​

(24,967,931)

​

​

—

​

​

2,036,476

​

​

—

​

​

(6,532,955)

​

​

(29,464,410)

Balance as of June 30,2021

​

​

(146,395,455)

​

​

—

​

​

6,743,106

​

​

(43,656,170)

​

​

—

​

​

(183,308,519)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2021

​

 

​

​

 

​

​

​

​

​

​

​

​

​

​

​

 

​

Net Loss

​

$

(51,575,491)

​

$

—

​

$

3,993,325

​

$

—

​

​

(6,532,953)

​

$

(54,115,119)

Health Plan Settlements Receivable/Premiums Receivable

​

​

(5,320,861)

​

​

—

​

​

—

​

​

—

​

​

6,532,953

​

​

1,212,092

Class A and Class D Preferred Returns

​

 

3,993,325

​

 

—

​

​

(3,993,325)

​

​

—

​

​

—

​

 

—

*Rounding may cause variances

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

As Previously

    

Network

    

Preferred Returns

    

Class A Units

    

Revenue

    

    

​

​

​

Reported

​

Adjustment

​

Adjustment

​

Adjustments

​

Adjustment

​

As Restated

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Balance Sheet as of March 31, 2021 (Unaudited)

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

Health Plan Settlement Receivables

​

$

3,687,918

​

$

—

​

$

—

​

$

—

​

$

6,532,954

​

$

10,220,872

Total Current Assets

​

​

78,762,484

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

85,295,438

Total Assets

​

​

94,189,692

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

100,722,646

Class A Units Subject to Possible Redemption

​

​

—

​

​

—

​

​

—

​

​

43,656,270

​

​

—

​

​

43,656,270

Class D Units Subject to Possible Redemption

​

​

52,675,137

​

​

—

​

​

(5,633,583)

​

​

—

​

​

—

​

​

47,041,554

Contributed Capital

​

​

41,764,270

​

​

—

​

​

—

​

​

(41,764,270)

​

​

—

​

​

—

Class A Preferred Returns

​

​

4,705,644

​

​

—

​

​

(4,705,644)

​

​

—

​

​

—

​

​

—

Accumulated Equity-Based Compensation

​

​

1,829,084

​

​

—

​

​

—

​

​

(921,092)

​

​

—

​

​

907,992

Retained Loss from Non-Controlling Interests

​

 

(21,469,673)

​

 

21,469,673

​

 

—

​

 

—

​

 

—

​

 

—

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

​

​

(149,567,493)

​

​

(21,469,673)

​

​

10,339,227

​

​

(970,908)

​

​

6,532,954

​

​

(155,135,893)

Total Liabilities, Mezzanine Equity & Members' Equity (Deficit)

​

​

94,189,692

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

100,722,646

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Three Months Ended March 31, 2021 (Unaudited)

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Capitated Revenue

​

$

147,700,465

​

$

—

​

$

—

​

$

—

​

$

1,263,725

​

$

148,964,190

Other Patient Service Revenue

​

​

3,863,915

​

​

—

​

​

—

​

​

—

​

​

(1,530,165)

​

​

2,333,750

Total Operating Revenue

​

​

151,564,380

​

​

—

​

​

—

​

​

—

​

​

(266,440)

​

​

151,297,940

Medical Expenses

​

​

146,890,945

​

​

—

​

​

—

​

​

—

​

​

(266,440)

​

​

146,624,505

Total Operating Expenses

​

​

164,552,810

​

​

—

​

​

—

​

​

—

​

​

(266,440)

​

​

164,286,370

Interest Expense, net

​

​

(4,081,134)

​

​

—

​

​

1,956,848

​

​

—

​

​

—

​

​

(2,124,286)

Total Other Expenses

​

​

(13,619,130)

​

​

—

​

​

1,956,848

​

​

—

​

​

—

​

​

(11,662,282)

Net Loss Attributable to Non-Controlling Interests

​

 

(3,282,292)

​

 

3,282,292

​

​

—

​

 

—

​

 

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(23,325,268)

​

 

(3,282,292)

​

 

1,956,848

​

 

—

​

 

—

​

 

(24,650,712)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Changes in Members' Deficit for the 3 Months Ended March 31, 2021

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Preferred Return at 8% for Class A Units

​

$

890,612

​

$

—

​

$

(890,612)

​

$

—

​

​

—

​

$

—

Net Loss

​

 

(26,607,560)

​

 

—

​

 

1,956,848

​

 

—

​

​

—

​

 

(24,650,712)

Balance as of March 31,2021

​

​

(122,918,168)

​

​

—

​

​

5,633,581

​

​

(43,656,269)

​

​

6,532,954

​

​

(154,407,902)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Cash Flows for the 3 Months Ended March 31, 2021

​

 

  

​

 

  

​

 

  

​

 

  

​

​

  

​

 

  

Net Loss

​

$

(26,607,560)

​

$

—

​

$

1,956,848

​

​

—

​

​

—

​

$

(24,650,712)

Class A and Class D Preferred Returns

​

 

1,956,848

​

 

—

​

 

(1,956,848)

​

 

—

​

​

—

​

 

—

*Rounding may cause variances

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

As Previously

    

Network

    

Preferred Returns

    

Class A Units

    

Capitated Revenue

    

    

​

​

​

Reported

​

Adjustments

​

Adjustments

​

Adjustments

​

Adjustments

​

As Restated

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Nine Months Ended September 30, 2020 (Unaudited)

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

Capitated Revenue

​

$

351,018,290

​

$

—

​

$

—

​

$

—

​

$

1,630,111

​

$

352,648,401

Other Patient Service Revenue

​

​

9,645,990

​

​

—

​

​

—

​

​

—

​

​

(2,230,451)

​

​

7,415,539

Total Operating Revenue

​

​

360,664,280

​

​

—

​

​

—

​

​

—

​

​

(600,340)

​

​

360,063,940

Medical Expenses

​

​

348,258,272

​

​

—

​

​

—

​

​

—

​

​

(600,340)

​

​

347,657,932

Total Operating Expenses

​

​

384,971,257

​

​

—

​

​

—

​

​

—

​

​

(600,340)

​

​

384,370,917

Interest Expense, net

​

​

(6,877,619)

​

​

—

​

​

5,577,812

​

​

—

​

​

—

​

​

(1,299,807)

Total Other Expenses

​

​

(6,877,619)

​

​

—

​

​

5,577,812

​

​

—

​

​

—

​

​

(1,299,807)

Net Loss Attributable to Non-Controlling Interests

​

 

(3,449,955)

​

 

3,449,955

​

 

—

​

 

—

​

 

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(27,734,641)

​

 

(3,449,955)

​

 

5,577,812

​

 

—

​

 

—

​

 

(25,606,784)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Three Months Ended September 30, 2020 (Unaudited)

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Capitated Revenue

​

$

124,461,275

​

$

—

​

$

—

​

$

—

​

$

721,351

​

$

125,182,626

Other Patient Service Revenue

​

​

4,379,716

​

​

—

​

​

—

​

​

—

​

​

(1,018,851)

​

​

3,360,865

Total Operating Revenue

​

​

128,840,991

​

​

—

​

​

—

​

​

—

​

​

(297,500)

​

​

128,543,491

Medical Expenses

​

​

127,015,976

​

​

—

​

​

—

​

​

—

​

​

(297,500)

​

​

126,718,476

Total Operating Expenses

​

​

142,355,570

​

​

—

​

​

—

​

​

—

​

​

(297,500)

​

​

142,058,070

Interest Expense, net

​

​

(2,316,579)

​

​

—

​

​

1,859,270

​

​

—

​

​

—

​

​

(457,309)

Total Other Expenses

​

​

(2,316,579)

​

​

—

​

​

1,859,270

​

​

—

​

​

—

​

​

(457,309)

Net Income Attributable to Non-Controlling Interests

​

 

875,560

​

 

(875,560)

​

 

—

​

 

—

​

 

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(16,706,718)

​

 

875,560

​

 

1,859,270

​

 

—

​

 

—

​

 

(13,971,888)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Changes in Members' Deficit for the 9 Months Ended September 30, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Preferred Return at 8% for Class A Units

​

$

2,534,853

​

$

—

​

$

(2,534,853)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(31,184,596)

​

 

—

​

 

5,577,812

​

 

—

​

 

—

​

 

(25,606,784)

Balance as of September 30, 2020

​

​

(84,110,848)

​

​

—

​

​

3,558,027

​

​

(43,656,271)

​

​

—

​

​

(124,209,092)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Changes in Members' Deficit for the 3 Months Ended September 30, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Preferred Return at 8% for Class A Units

​

$

840,805

​

$

—

​

$

(840,805)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(15,831,158)

​

 

—

​

 

1,859,270

​

 

—

​

 

—

​

 

(13,971,888)

Balance as of September 30, 2020

​

​

(84,110,848)

​

​

—

​

​

3,558,027

​

​

(43,656,271)

​

​

—

​

​

(124,209,092)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Cash Flows for the 9 Months Ended September 30, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Net Loss

​

$

(31,184,596)

​

$

—

​

$

5,577,812

​

$

—

​

$

—

​

$

(25,606,784)

Class A and Class D Preferred Returns

​

 

5,577,812

​

 

—

​

 

(5,577,812)

​

 

—

​

 

—

​

 

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

As Previously

    

Network

    

Preferred Returns

    

Class A Units

    

Captital Revenue

    

    

​

​

​

Reported

​

Adjustments

​

Adjustments

​

Adjustments

​

Adjustments

​

As Restated

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Six Months Ended June 30, 2020 (Unaudited)

 

​

  

 

​

  

 

​

  

 

​

  

​

​

​

 

​

  

Capitated Revenue

​

$

226,557,015

​

$

—

​

$

—

​

$

—

​

$

908,759

​

$

227,465,774

Other Patient Service Revenue

​

​

5,266,273

​

​

—

​

​

—

​

​

—

​

​

(1,211,599)

​

​

4,054,674

Total Operating Revenue

​

​

231,823,288

​

​

—

​

​

—

​

​

—

​

​

(302,840)

​

​

231,520,448

Medical Expenses

​

​

221,242,295

​

​

—

​

​

—

​

​

—

​

​

(302,840)

​

​

220,939,455

Total Operating Expenses

​

​

242,615,687

​

​

—

​

​

—

​

​

—

​

​

(302,840)

​

​

242,312,847

Interest Expense, net

​

​

(4,561,039)

​

​

—

​

​

3,718,542

​

​

—

​

​

—

​

​

(842,497)

Total Other Expenses

​

​

(4,561,039)

​

​

—

​

​

3,718,542

​

​

—

​

​

—

​

​

(842,497)

Net Loss Attributable to Non-Controlling Interests

​

 

(4,325,515)

​

 

4,325,515

​

 

—

​

 

—

​

​

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(11,027,923)

​

 

(4,325,515)

​

 

3,718,542

​

 

—

​

​

—

​

 

(11,634,896)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Three Months Ended June 30, 2020 (Unaudited)

​

 

  

​

 

  

​

 

  

​

 

  

​

​

​

​

 

  

Capitated Revenue

​

$

114,042,681

​

$

—

​

$

—

​

$

—

​

$

472,742

​

$

114,515,423

Other Patient Service Revenue

​

​

2,821,811

​

​

—

​

​

—

​

​

—

​

​

(624,782)

​

​

2,197,029

Total Operating Revenue

​

​

116,864,492

​

​

—

​

​

—

​

​

—

​

​

(152,040)

​

​

116,712,452

Medical Expenses

​

​

105,777,973

​

​

—

​

​

—

​

​

—

​

​

(152,040)

​

​

105,625,933

Total Operating Expenses

​

​

121,527,179

​

​

—

​

​

—

​

​

—

​

​

(152,040)

​

​

121,375,139

Interest Expense, net

​

​

(2,249,977)

​

​

—

​

​

1,859,271

​

​

—

​

​

—

​

​

(390,706)

Total Other Expenses

​

​

(2,299,977)

​

​

—

​

​

1,859,271

​

​

—

​

​

—

​

​

(440,706)

Net Loss Attributable to Non-Controlling Interests

​

 

(2,774,562)

​

 

2,774,562

​

 

—

​

 

—

​

​

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(4,188,102)

​

 

(2,774,562)

​

 

1,859,271

​

 

—

​

​

—

​

 

(5,103,393)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Changes in Members' Deficit for the 6 Months Ended June 30, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

​

​

​

 

  

Preferred Return at 8% for Class A Units

​

$

1,694,048

​

$

—

​

$

(1,694,048)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(15,353,438)

​

 

—

​

 

3,718,542

​

 

—

​

​

—

​

 

(11,634,896)

Balance as of June 30, 2020

​

​

(69,173,164)

​

​

—

​

​

2,539,562

​

​

(43,656,272)

​

​

—

​

​

(110,289,874)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Changes in Members' Deficit for the 3 Months Ended June 30, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

​

​

​

 

  

Preferred Return at 8% for Class A Units

​

$

847,048

​

$

—

​

$

(847,048)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(6,962,664)

​

 

—

​

 

1,859,271

​

 

—

​

​

—

​

 

(5,103,393)

Balance as of June 30, 2020

​

​

(69,173,164)

​

​

—

​

​

2,539,562

​

​

(43,656,272)

​

​

—

​

​

(110,289,874)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Cash Flows for the 6 Months Ended June 30, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

​

​

​

 

  

Net Loss

​

$

(15,353,438)

​

$

—

​

$

3,718,542

​

$

—

​

$

—

​

$

(11,634,896)

Class A and Class D Preferred Returns

​

 

3,718,542

​

 

—

​

 

(3,718,542)

​

 

—

​

​

—

​

 

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As Previously

​

Network

​

Preferred Returns

​

Class A Units

​

Capitated Revenue

​

​

​

​

​

Reported

​

Adjustments

​

Adjustments

​

Adjustments

    

Adjustments

​

As Restated

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Three Months Ended March 31, 2020 (Unaudited)

 

​

  

 

​

  

 

​

  

 

​

  

​

​

​

 

​

  

Capitated Revenue

​

$

112,514,334

​

$

—

​

$

—

​

$

—

​

$

436,017

​

$

112,950,351

Other Patient Service Revenue

​

​

2,444,462

​

​

—

​

​

—

​

​

—

​

​

(586,817)

​

​

1,857,645

Total Operating Revenue

​

​

114,958,796

​

​

—

​

​

—

​

​

—

​

​

(150,800)

​

​

114,807,996

Medical Expenses

​

​

115,464,322

​

​

—

​

​

—

​

​

—

​

​

(150,800)

​

​

115,313,522

Total Operating Expenses

​

​

121,088,507

​

​

—

​

​

—

​

​

—

​

​

(150,800)

​

​

120,937,707

Interest Expense, net

​

​

(2,261,063)

​

​

—

​

​

1,859,271

​

​

—

​

​

—

​

​

(401,792)

Total Other Expenses

​

​

(2,261,063)

​

​

—

​

​

1,859,271

​

​

—

​

​

—

​

​

(401,792)

Net Loss Attributable to Non-Controlling Interests

​

 

(1,550,953)

​

 

1,550,953

​

 

—

​

 

—

​

​

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(6,839,821)

​

 

(1,550,953)

​

 

1,859,271

​

 

—

​

​

—

​

 

(6,531,503)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Changes in Members' Deficit for the 3 Months Ended March 31, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

​

​

​

 

  

Preferred Return at 8% for Class A Units

​

$

846,999

​

$

—

​

$

(846,999)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(8,390,774)

​

 

—

​

 

1,859,271

​

 

—

​

​

—

​

 

(6,531,503)

Balance as of March 31, 2020

​

​

(63,212,106)

​

​

—

​

​

1,527,340

​

​

(43,656,272)

​

​

—

​

​

(105,341,038)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Cash Flows for the 3 Months Ended March 31, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

​

​

​

 

  

Net Loss

​

$

(8,390,774)

​

$

—

​

$

1,859,271

​

$

—

​

$

—

​

$

(6,531,503)

Class A and Class D Preferred Returns

​

 

1,859,271

​

 

—

​

 

(1,859,271)

​

 

—

​

​

—

​

 

—